| P50 | author | Jaap van Dissel | Q77084532 |
| P2093 | author name string | Romano Danesi | |
| | Peter H Nibbering | |
| | Antonella Lupetti | |
| | Sonia Senesi | |
| | Jan W van 't Wout | |
| P2860 | cites work | Candidacidal activities of human lactoferrin peptides derived from the N terminus | Q24290527 |
| | Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic | Q24290539 |
| | Salivary histatin 5 is an inhibitor of both host and bacterial enzymes implicated in periodontal disease | Q24548705 |
| | Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung | Q24564556 |
| | Discovery of new human beta-defensins using a genomics-based approach | Q28202377 |
| | Characterization of low-molecular-weight peptides in human parotid saliva | Q28235643 |
| | A peptide antibiotic from human skin | Q28242199 |
| | Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis | Q28303994 |
| | Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors | Q28344744 |
| | Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa | Q28492663 |
| | A PhoP-regulated outer membrane protease of Salmonella enterica serovar typhimurium promotes resistance to alpha-helical antimicrobial peptides. | Q30453404 |
| | Synergistic effects of low doses of histatin 5 and its analogues on amphotericin B anti-mycotic activity. | Q32010164 |
| | Antimicrobial peptides in mammalian and insect host defence | Q33536544 |
| | Identification of constituents of human neutrophil azurophil granules that mediate fungistasis against Histoplasma capsulatum | Q33591833 |
| | Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents | Q33689421 |
| | Complete response of severe, refractory oral candidiasis to mouthwash containing lactoferrin and lysozyme | Q33926040 |
| | Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. | Q33929546 |
| | Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways. | Q33980976 |
| | Evolution of drug resistance in experimental populations of Candida albicans. | Q33994006 |
| | Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex. | Q34005092 |
| | Released ATP is an extracellular cytotoxic mediator in salivary histatin 5-induced killing of Candida albicans | Q34005242 |
| | Lactoferrin peptide increases the survival of Candida albicans-inoculated mice by upregulating neutrophil and macrophage functions, especially in combination with amphotericin B and granulocyte-macrophage colony-stimulating factor | Q34007871 |
| | Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli | Q34503697 |
| | Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family | Q34745204 |
| | Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine | Q36369306 |
| | Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. | Q36899142 |
| | Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells | Q38297718 |
| | The R467K amino acid substitution in Candida albicans sterol 14alpha-demethylase causes drug resistance through reduced affinity. | Q39472566 |
| | Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5. | Q39472812 |
| | Transcriptional analyses of antifungal drug resistance in Candida albicans. | Q39474832 |
| | Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans. | Q39475859 |
| | Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria. | Q39518711 |
| | 19F nuclear magnetic resonance study of fluoropyrimidine metabolism in strains of Candida glabrata with specific defects in pyrimidine metabolism | Q39816994 |
| | Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. | Q40969107 |
| | N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA | Q41990276 |
| | Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells | Q43572155 |
| | A novel bovine lactoferrin peptide, FKCRRWQWRM, suppresses Candida cell growth and activates neutrophils | Q43572569 |
| | Engineered salt-insensitive alpha-defensins with end-to-end circularized structures | Q50122491 |
| | Fungal colonization of haematological patients receiving cytotoxic chemotherapy: emergence of azole-resistant Saccharomyces cerevisiae. | Q51192481 |
| | Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. | Q51192827 |
| | Antifungal activity of histatin-5 against non-albicans Candida species. | Q52059435 |
| | Fluconazole-resistant Candida species in the oral flora of fluconazole-exposed HIV-positive patients. | Q54135688 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antimicrobial peptide | Q1201508 |
| P304 | page(s) | 309-318 | |
| P577 | publication date | 2002-02-01 | |
| P1433 | published in | Expert Opinion on Investigational Drugs | Q5421208 |
| P1476 | title | Antimicrobial peptides: therapeutic potential for the treatment of Candida infections | |
| P478 | volume | 11 | |